Cited by 770Hepatitis C virus researchLiver physiology and pathologyLiver Disease Diagnosis and Treatment

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Hepatitis C: the clinical spectrum of disease.

Open access

Hoofnagle, J H·1997·Hepatology

Open this paper in CoChat — free account Open PDF

Abstract

Hepatitis C virus (HCV) accounts for approximately 20% of cases of acute hepatitis, 70% of chronic hepatitis, and 30% of end-stage liver disease in the United States. The acute infection has an incubation period of 7 weeks (range, 4-20 weeks) and is symptomatic and icteric in only one third of patients. Serum aminotransferase levels generally increase greater than 10-fold elevated and as symptoms and signs resolve decrease into the normal range. Antibody to HCV is usually but not always present at the time of onset of symptoms. HCV RNA appears in the serum early during the incubation period, increases in titer and peaks at the time of symptoms, and then disappears in resolving disease. Importantly, 85% of patients with acute HCV infection develop chronic infection. In these patients, HCV RNA remains present and in approximately two thirds of patients, aminotransferases remain elevated in the range of 1.5- to 10-fold the upper limit of normal. The course of chronic hepatitis C is variable. Probably fewer than 20% of patients have symptoms and they are usually intermittent, vague, and nonspecific, largely being malaise and easy fatiguability. A small percentage of patients develop extrahepatic manifestations of hepatitis C, including cryoglobulinemia and glomerulonephritis. It is estimated that 20% to 30% of patients with chronic hepatitis C develop cirrhosis, but the process is generally slow and insidious. Once cirrhosis develops, symptoms are more common and the signs of end-stage liver disease can appear with jaundice, weakness, wasting, and gastrointestinal bleeding. Patients with cirrhosis are also at risk for developing hepatocellular carcinoma. Thus, this important liver disease has protean manifestations but is often insidious and can lead to end-stage liver disease despite the presence of few symptoms and signs of illness.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/hep.510260703

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Classification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M. A., Hoofnagle, J. H., Manns, M. P., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,591
Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis
Alter, H. J., Purcell, R. H., Shih, J. W., Melpolder, J. C., Houghton, M., Choo, Q.-L., & Kuo, G. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911303212202 · Cited by 1,658
Clinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,191
Long-Term Outcome of Hepatitis C Infection after Liver Transplantation
Gane, E. J., Portmann, B. C., Naoumov, N. V., Smith, H. M., Underhill, J. A., Donaldson, P. T., Maertens, G. G., & Williams, R. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603283341302 · Cited by 963
Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection
Johnson, R. J., Gretch, D. R., Yamabe, H., Hart, J., Bacchi, C. E., Hartwell, P., Couser, W. G., Corey, L., Wener, M. H., Alpers, C. E., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302183280703 · Cited by 870
Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease
Houghton, M., Weiner, A. J., Han, J. H., Kuo, G. C., & Choo, Q. (1991) · Hepatology · doi:10.1002/hep.1840140227 · Cited by 862
Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.
Weiner, A. J., Geysen, H. M., Christopherson, C., Hall, J. E., Mason, T. J., Saracco, G. M., Bonino, F., Crawford, K., Marion, C. D., & Crawford, K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3468 · Cited by 703
Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
Seeff, L. B., Buskell‐Bales, Z., Wright, E. C., Durako, S. J., Alter, H. J., Iber, F. L., Hollinger, F. B., Gitnick, G., Knodell, R. G., Perrillo, R. P., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272703 · Cited by 668
PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Colombo, M., Choo, Q. L., Ninno, E. D., Dioguardi, N., Kuo, G. C., Donato, M. F., Tommasini, M., & Houghton, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91016-7 · Cited by 666
Routes of Infection, Viremia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus Infection
Conry‐Cantilena, C., VanRaden, M. J., Gibble, J. W., Melpolder, J. C., Shakil, A. O., Viladomiu, L., Cheung, L., DIBISCEGLIE, A., Hoofnagle, J. H., Shih, J. W., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342602 · Cited by 627

Flagged first, then by citations

Show all 47 references

Research works printed but not linked: 6

Serfaty L, Nousbaum JB, Elghouzzi MH, Giral P, Legendre C, Poupon followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494-1500.
Barrera JM, Bruguera M, Guadalupe-Ercilla M, Gil C, Celis R, Gil MP, del Valle Onorato M, et al. Persistent hepatitis C viremia after acute HEPATOLOGY 1995;21:725-729.
Morales TG, Sampliner RE, Bhattacharyya A, Alter MJ. Liver histology self-limiting posttransfusion hepatitis C. HEPATOLOGY 1995;21:639-644.
Alter MJ, Hadler SC, Judson FN, Mares A, Alexander J, Hu PY, Miller in anti-HCV positive persons with normal or minimally elevated amino- transferases. J Clin Gastroenterol 1995;21:301-305.
Farci P, Alter HJ, Wong D, Miller RH, Shih JW, Jett B, Purcell RH. A non-A, non-B hepatitis. N Engl J Med 1992;327:1906-1911.
Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Don- 1995;123:897-903.

Sorted by citations

Items 601–700 of 770

Spontaneous viral clearance of chronic HCV infection in Upper Egypt: A community-based study with a 10year follow-up
El-Attar, M., Ahmed, M. A.-H., Hasan, M. S., Aly, M. A., & Nasr, A. M. (2010) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2010.10.001 · Cited by 2
Knowledge, attitude and behavior of primary health care workers about hepatitis C, Kuwait.
Yaghi, S. A., Al-Habib, E. S., Sadik, A. A., Almutairi, G. R., Makboul, G., & El-Shazly, M. K. (2012) · Greener Journal of Medical Sciences · doi:10.15580/gjms.2012.4.gjms1222 · Cited by 2
Health-related quality of life in children with chronic hepatitis C
Behairy, O. G. A. (2016) · Egyptian Pediatric Association Gazette · doi:10.1016/j.epag.2016.08.001 · Cited by 2
Inhibition of Hepatitis C virus by nucleic acid-based antiviral approaches
Frese, M., & Bartenschlager, R. F. W. (2007) · Springer eBooks · doi:10.1007/978-0-387-31047-3_3 · Cited by 2
Universal screening for hepatitis C — in for a penny, in for a pound
Garrido, I., & Macedo, G. (2022) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04395-z · Cited by 2
4 Acute hepatitis C
Hoofnagle, J. H. (2000) · Biomedical research reports · doi:10.1016/s1874-5326(00)80008-3 · Cited by 2
Design and Synthesis of Inhibitors Targeting the Hepatitis C Virus NS3 Protease : Focus on C-Terminal Acyl Sulfonamides
Rönn, R. (2007) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 2
Hepatitis infection in haemodialysis patients
Huang, C.-C. (2002) · Nephrology · doi:10.1046/j.1440-1797.2002.00105.x · Cited by 2
Hepatitis C: A Challenge for the Generalist
Catalina, G., & Navarro, V. J. (2000) · Hospital Practice · doi:10.3810/hp.2000.01.180 · Cited by 2
L'histoire naturelle de l'infection par le virus de l'hépatite c
Miailhes, P., & TREPO, C. G. (2000) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(00)88855-1 · Cited by 2
Current views on hepatitis C virus infection
Epstein, M. P., & Knox, T. A. (2000) · Current Infectious Disease Reports · doi:10.1007/s11908-000-0088-7 · Cited by 2
Prevalence of Hepatitis C Virus in Nigeria: a Protocol for Systematic Review and Meta-analysisPreprint
Okoye, H. C., Nna, E. O., Onuka, S., Afolabi, B. M., Onwusulu, D. N., Nnamani, A. O., Ikeagwulonu, R. C., Duru, A. N., Obu, D. C., Akanni, O. O., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-144655/v1 · Cited by 2
The Proteinases Encoded by Hepatitis C Virus as Therapeutic Targets
Steinkühler, C., Koch, U., Francesco, R. D., & Pessi, A. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57092-6_5 · Cited by 2
Differences in Provider Hepatitis C Virus Screening Recommendations by Patient Risk Status
Laily, A. N., Duncan, R. J., Gabhart, K. M., Nephew, L. D., Christy, S. M., Vadaparampil, S. T., Giuliano, A. R., & Kasting, M. L. (2024) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2024.102602 · Cited by 1
Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication: A Population-Based Cohort Study
Ríos, J., Sapena, V., Mariñó, Z., Bruix, J., Forns, X., Morros, R., Reig, M., Torres, F., & Pontes, C. (2024) · Drugs - Real World Outcomes · doi:10.1007/s40801-024-00437-y · Cited by 1
Implementation of a novel framework for hepatitis C diagnosis and treatment in an academic health system
Sheehan, L. P., Wright, M. P., Rhudy, C. N., Osborne, T., Platt, T., & Duckworth, D. L. (2024) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxae373 · Cited by 1
16 Hepatitis C virus and human immunodeficiency virus coinfection
Ghany, M. G., & Lau, D. (2000) · Biomedical research reports · doi:10.1016/s1874-5326(00)80020-4 · Cited by 1
Cognitive Function, Mood and Health-Related Quality of Life in Hepatitis C Virus-Infected Individuals
Thein, H., & Dore, G. J. (2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_191 · Cited by 1
Differential diagnosis of human hepatitis
Sprinzl, M. F., & Galle, P. R. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8558-3_2 · Cited by 1
Brothers in harm
Barrett, L. F., & Grant, M. D. (2002) · Clinical and Applied Immunology Reviews · doi:10.1016/s1529-1049(02)00042-9 · Cited by 1
Proteome Analysis Identifies the Role of Heat Stress in Production of Progeny HCV in Huh7 Cells Harboring Intact HCV
Zhao, S., Xun, M., Chu, Y., Zhu, T., Wang, Y., Yan, L.-P., Xun, X., Xu, K., Song, J., & Shao, M. (2008) · Intervirology · doi:10.1159/000151631 · Cited by 1
Peginterferon plus Chinese herbal therapy is associated with a higher virological response than only peginterferon therapy in chronic hepatitis C
Cheng, D., Liu, E., Li, Y., Liu, R., Bai, L., Chen, Y., Wang, Y., Chu, Y., Wu, M., Cheng, G., et al. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1973-y · Cited by 1
Management and treatment of hepatitis C: A review
Daryani, N. E., Mousavi, S. H., & Keramati, M. R. (2008) · Archives of Clinical Infectious Diseases · Cited by 1
PRE - TREATMENT ANXIETY AND INTERFERON INDUCED DEPRESSION IN HEPATITIS C PATIENTS
Andleeb, S., Jahangir, F., & Shaheen, N. (2016) · Journal of Postgraduate Medical Institute · Cited by 1
Dental and Orofacial Health and Hepatitis C
McLean, A. T., Scopacasa, B., NAIR, R. G., Coates, E., Sherson, W., Batey, R. G., Woolley, N., & Seager, K. (2012) · Griffith Research Online · Cited by 1
Intrahepatic Cholestasis of Pregnancy with Severe Elevation of Bile Acids in the Setting of Acute Hepatitis C Infection
Lawlor, M. L., & Critchfield, A. S. (2016) · Case Reports in Obstetrics and Gynecology · doi:10.1155/2016/4963283 · Cited by 1
Hepatitis C: diagnosis and management issues
Talley, N., & Talley, N. J. (2006) · Cited by 1
A PREDICTIVE AND COMPARATIVE STUDY VIA VIRAL AND BIOCHEMICAL MEASUREMENTS FOR RESPONDERS AND NON-RESPONDERS EGYPTIAN HEPATITIS C PATIENTS TO DACLATASVIR PLUS SOFOSBUVIR THERAPY
Elgebaly, A. S. (2018) · Al-Azhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences · doi:10.21608/ajps.2018.46639 · Cited by 1
Study of Co-Relation between Hepatitis C Viral Load with Clinical Presentations, Laboratory Investigations and Sofosbuvir Combination Therapy
Gautam, B. (2019) · Virology & Immunology Journal · doi:10.23880/vij-16000223 · Cited by 1
The Relationship Between Anti-HCV Screening and Clinical Features of Inpatients in Addiction Center
Karabulut, S. (2022) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.27965 · Cited by 1
Host-Related Predictors of Persistence of Hepatitis C Virus Infection
Mohamed, E.-G. E., & Farghaly, A. G. (2019) · Journal of Infectious Diseases and Epidemiology · doi:10.23937/2474-3658/1510100 · Cited by 1
Computational Approaches for the Discovery of Novel Hepatitis C Virus NS3/4A and NS5B Inhibitors
Thai, K., Dong, Q.-H., Nguyen, T.-T.-L., Le, D.-P., Le, M.-T., & Tran, T. (2016) · IGI Global eBooks · doi:10.4018/978-1-5225-0549-5.ch017 · Cited by 1
Hepatitis C: epidemiology, natural history, and diagnosis
Ogawa, E., & Nguyen, M. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98368-6.00015-x · Cited by 1
Deep Learning-Assisted Design of de novo Protein Binders Targeting Hepatitis C Virus E2 Protein
Al-Hayani, N. N., Mohaisen, M. R., & Rashid, S. A. A. (2024) · Mathematical Biology and Bioinformatics · doi:10.17537/2024.19.402 · Cited by 1
All patients with acute hepatitis must be observed until the acute liver injury resolves.
Johnston, D. E. (2000) · Western Journal of Medicine · doi:10.1136/ewjm.172.1.32 · Cited by 1
Profound jaundice in a patient with acute hepatitis C
Lohia, P., Jinjuvadia, R., & May, E. (2013) · BMJ Case Reports · doi:10.1136/bcr-2013-200233 · Cited by 1
Seroprevalence of Hepatitis C Virus (HCV) antibodies in pregnant women in Anyigba, Kogi State, North Central Nigeria
Nwankwo, E., Lawal, A., & Abba, M. (2016) · African Journal of Clinical and Experimental Microbiology · doi:10.4314/ajcem.v17i3.10 · Cited by 1
Budd-Chiari Syndrome in a Patient with Hepatitis C
Frankl, J. A., Hennemeyer, C. T., Flores, M., & Desai, A. P. (2016) · Case Reports in Hepatology · doi:10.1155/2016/7493970 · Cited by 1
ASSOCIATION OF LICHEN PLANUS AND HEPATITIS C VIRUS
Sreedevi, L., Sreekala, J., & Reddy, I. C. S. (2016) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2016/863 · Cited by 1
A Critical Risk Factor for a Major Side Effect of Interferon-Alpha Therapy: Activated Indoleamine 2,3-Dioxygenase 1 is Related to Depressive Symptoms
Murakami, Y., & Imamura, Y. (2018) · InTech eBooks · doi:10.5772/intechopen.71013 · Cited by 1
Hepatitis C Virus Infection Caused by Infrequent Exposure in China Should Be of Concern
Qin, X.-C., Zhong, L., Zhū, L., Plyusnin, A., & Zhāng, Y.-Z. (2020) · Virologica Sinica · doi:10.1007/s12250-019-00191-4 · Cited by 1
HIV and Hepatitis C in Corrections: A Public Health Opportunity
Bick, J. A. (2021) · Springer eBooks · doi:10.1007/978-1-0716-1807-3_8 · Cited by 1
Quality of Life and Associated Factors in Patients Infected with Hepatitis B and C Virus in a Moroccan Region: A Cross-Sectional Study
Diagne, B. J., Hakima, A., Harch, I. E., Benmaamar, S., Hind, B., Bahra, N., Baldé, M., Passy, C., Otmani, N., Abkari, M. E., et al. (2022) · OALib · doi:10.4236/oalib.1108781 · Cited by 1
Natural History of Hepatitis C
Everson, G. T. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-104-6_4 · Cited by 2
Viral Mechanisms of Human Carcinogenesis
Hoppe‐Seyler, F., & Butz, K. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-125-1_12 · Cited by 1
Hepatitis and Hemophilia
Makris, M., & Dusheiko, G. M. (2010) · doi:10.1002/9781444318555.ch33 · Cited by 1
Hepatitis C virus
Muerhoff, A. S., & Dawson, G. J. (2003) · Perspectives in medical virology · doi:10.1016/s0168-7069(03)10005-5 · Cited by 1
Research questions concerning hepatitis C virus: Report from a workshop at the Harvard Center for Cancer Prevention
Cradock, A. L. I. (1999) · Cancer Causes & Control · doi:10.1023/a:1008914103840 · Cited by 1
Gastrointestinal complications in dialysis patients
Gonin, J. M., Kitiyakara, C., & Santos, A. H. (2004) · Springer eBooks · doi:10.1007/978-1-4020-2275-3_35 · Cited by 1
Role of Core Protein-Induced Oxidative Stress in the Pathogenesis of Hepatitis C
Weinman, S. A., Okuda, M., Li, K., Showalter, L., Otani, K., Lemon, S. M., & Beard, M. R. (2003) · Springer eBooks · doi:10.1007/978-4-431-67005-6_2 · Cited by 1
Alpha Glutationa S Transferase: marcador de lesão hepática em pacientes com hepatite pelo vírus C?
Júnior, E. A. B. D. O. (2005) · doi:10.11606/t.5.2005.tde-19032007-101313 · Cited by 1
Avaliação de fatores de risco para infecção pelo vírus da hepatite C em candidatos à doação de sangue como potencial instrumento de redução de risco transfusional
Valois, R. C. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Interacción del virus de la hepatitis C con la membrana celular
Sanz-Cameno, P., Borque, M. J., Garcı́a-Buey, L., & Moreno‐Otero, R. (2002) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(02)70304-x · Cited by 1
Clínica de la hepatitis vírica
Buey, L. G., & González-Mateos, F. (2000) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(00)70129-6 · Cited by 1
The economic aspects of hepatitis C – implications for haemophilia
Roberts (1999) · Haemophilia · doi:10.1046/j.1365-2516.1999.00363.x · Cited by 1
What lies ahead and can we afford it?
Howie, H., & Hutchinson, S. J. (2004) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2004.00572.x · Cited by 1
Mutation patterns for two flaviviruses: hepatitis C virus and GB virus C/hepatitis G virus
Mizokami, M., Imanishi, T., Ikeo, K., Suzuki, Y., Orito, E., Kumada, T., Ueda, R., Iino, S., & Nakano, T. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00507-4 · Cited by 1
Long-term insured lives morbidity and mortality risk associated with chronic hepatitis C virus infection.
Pokorski, R. J. (2000) · PubMed · Cited by 1
Acute hepatitis C treatment
de Almeida, P. R. L. (2010) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31734-x · Cited by 1
Interferon-α-2b Plus Ribavirin A Review of its Use in the Management of Chronic Hepatitis C
Christensson, B., Kakamu, S., Mieli‐Vergani, G., Sterling, R. K., & Shiffman, M. L. (2002) · Cited by 1
Fatigue und Lebensqualität bei Patienten mit chronischer Hepatitis C
Güner-Capraz, N., & Matern, S. (2005) · RWTH Publications (RWTH Aachen) · Cited by 1
"Avaliação de qualidade de vida em candidatos à doação de sangue, portadores do vírus da hepatite C"
Teixeira, M. C. D. (2005) · doi:10.11606/t.5.2005.tde-11042006-120310 · Cited by 1
Akute und chronische Hepatitis
Dienes, H. P., & Drebber, U. (2020) · Pathologie · doi:10.1007/978-3-642-04557-8_7 · Cited by 1
Appendices
MSc, R. S. E. R., & BSc, M. J. W. (2008) · Wiley eBooks · doi:10.1002/9781444302448.app1
Quality of life in chronic liver diseases and in hepatic encephalopathy
Córdoba, J. (2007) · Springer eBooks · doi:10.1007/1-4020-4456-9_34 · Cited by 1
Herbal and Non-Traditional Therapies for Viral Hepatitis
Gagovic, V., & Kwo, P. Y. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-565-7_11 · Cited by 1
Epidemiological insights on the association between female genital mutilation and Hepatitis C Infection in Egypt: An Examination using Demographic and Health Survey data of Egypt, 2008.
Jabbar, S. F. (2022) · Digital Archive @ GSU · doi:10.57709/4115379
Avaliação do desempenho de testes rápidos para a detecção do anti-HCV
da Rosa, L. (2013)
Nuclease resistant ribozymes directed against hepatitis C virus RNA plus and minus strand inhibit viral replication of a HCV/poliovirus chimera
Blatt, L. M., Jensen, K. L., Bellon, L., Jamison, S. F., Pavco, P. A., & Macejak, D. G. (2003) · Elsevier eBooks · doi:10.1016/b978-044450986-4/50077-1
Developing Therapeutic Plans for Patients with Chronic Hepatitis B or C
Reindollar, R. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-104-6_10
Glycosylation and hepatacellular carcinoma
Mehta, A. S. (2005) · Encyclopedia of Genetics, Genomics, Proteomics and Bioinformatics · doi:10.1002/047001153x.g305220
Evaluation of Increased Serum Aminotransferase Level in Asymptomatic Patient
Cahyono, S. B. (2011) · The Indonesian Journal of Gastroenterology Hepatology and Digestive Endoscopy · doi:10.24871/1222011109-115
Analysis of the role of p7 protein function in hepatitis C virus life cycle
Atoom, A. M. (2014) · Memorial University Research Repository (Memorial University)
Probing the interaction of Hepatitis C virus glycoproteins with putative receptors and neutralising antibodies
Mirza, D. (2012) · Nottingham ePrints (University of Nottingham)
The effect of iron on hepatitis C virus replication
Clark, H. (2011) · Murdoch University Research Portal
O papel das mutações do gene HFE e da sobrecarga de ferro na evolução da hepatite crônica pelo VHC
da Silva, A. L. B. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2009.tde-08122009-181724
[HBV and HCV co-infections in HIV positive patients in the "HAART era": new challenges].
Laufer, N., Quarleri, J. F., Bouzas, M. B., Pérez, H. M., Salomón, H., & Cahn, P. E. (2007) · PubMed
Bedeutung eines prädizierten Leuzinzippermotivs im NS4B-Protein des Hepatitis-C-Virus für NS4B-Proteininteraktionen
Meyer, A. K. (2012) · Publications of the UdS (Saarland University) · doi:10.22028/d291-21633
Análise de sobrevida de pacientes coinfectados HIV/HCV de um centro de referência em DST/AIDS no município de São Paulo
Alencar, W. K. (2011) · doi:10.11606/d.6.2011.tde-30092011-133057
Κλινική και εργαστηριακή μελέτη ασθενών με τελικού σταδίου χρόνια νεφρική ανεπάρκεια και χρόνια HCV λοίμωξη
Σιάγκρης, Δ. (2002) · doi:10.12681/eadd/26355
Diagnostic et test du virus de l'hépatite C
Krajden, M. (2000) · doi:10.17269/cjph.91.1447
Detektion von Varianten und Polymorphismen im Nicht-Strukturprotein 5A des Hepatitis C Virusgenoms, die mit einer gesteigerten Resistenz oder Sensitivität des Virus gegenüber einer antiviralen Therapie mit Peg Inerferon alfa-2a und Ribavirin assoziiert sind
Kau, A. (2007) · Publications of the UdS (Saarland University) · doi:10.22028/d291-20996
Einfluss von chronischer Hepatitis C-Infektion und Interferon-alpha-Therapie auf den Serotoninstoffwechsel und Wertigkeit serotonerger Parameter als Prädiktoren für die Notwendigkeit einer antidepressiven Behandlung
Schlegel, H.-M. (2008) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-7473
Estudo dos alelos HLA classe II (LOCI DRB1 e DQB1) em pacientes infectados pelo virus da hepatite C
Corghi, D. B. (2005) · doi:10.47749/t/unicamp.2005.359572
Efeito do composto natural Yo Jyo Hen Shi Ko (YHK) no ciclo de replicação do vírus da hepatite C (VHC)
Pereira, I. V. A. (2014) · doi:10.11606/t.5.2014.tde-13012015-143326
Cost-effectiveness of Interferon Treatment for Hepatitis C
Henley, E. (1999) · JAMA · doi:10.1001/jama.281.22.2083
Chronic hepatitis - Part 1: Diagnosis
Blum, H. E., & Moradpour, D. (2001) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2001-15552
Indicaciones de derivación de las hipertransaminasemias de la medicina primaria a la especializada. criterios de ingreso hospitalario de las hipertransaminasemias
Monteagudo, J. A. M., Fernández‐Bermejo, M., & Iacono, O. L. (2000) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(00)70134-x
Aspects of the lipid profile in a cohort with chronic hepatitis C infection
Ramcharran, D. (2008) · D-Scholarship@Pitt (University of Pittsburgh)
Ocena wybranych parametrów biochemicznych krwi jako wskaźników stanu odżywienia dzieci i młodzieży z przewlekłym wirusowym zapaleniem wątroby typu B i C podczas monoterapii interferonem α
Sielużycka, A., Czerwionka‐Szaflarska, M., & Kuczyńska, R. (2008) · Pediatria Polska · doi:10.1016/s0031-3939(08)70188-4
Acute Infection With Hepatitis C Virus Can Cause Dilated Cardiomyopathy
Nguyen, H., & Solnick, J. V. (2002) · Infectious Diseases in Clinical Practice · doi:10.1097/01.idc.0000090387.89010.e7
485 Symptom prevalence and temporal clustering of symptoms in people living with chronic hepatitis C infection
Lang, C. A., Battistutta, D., Garrett, L., Cooksley, W. G. E., Dunne, M. P., & Macdonald, G. A. (2004) · Journal of Hepatology · doi:10.1016/s0168-8278(04)90485-0
Risk factors for Hepatitis C virus antibody seropositivity among children with sickle cell anaemia in Ilorin, Nigeria
Onuchukwu, C. E., Ojuawo, A., & Ernest, S. (2013) · African Journal of Clinical and Experimental Microbiology · doi:10.4314/ajcem.v14i3.2
Therapie chronischer viraler Hepatitiden
Böker, K. H. W., & Manns, M. P. (1999) · Der Internist · doi:10.1007/s001080050467
Δείκτες οξειδωτικού στρες λιπιδίων, DNA και πρωτεϊνών σε χρόνιες παθήσεις του ήπατος
Kaffe, E. (2010) · doi:10.12681/eadd/23192
Hepatitis C and skin disease
Egan, C. A., & Zone, J. J. (2000) · Current Problems in Dermatology · doi:10.1016/s1040-0486(00)90045-0
Exploring the Receptor-Based Virtual Screening Study of the Aromatic Substituents for the Hepatitis C Virus NS5B Polymerase by Docking and Scoring
Chen, P., Hsu, W.-T., Jhuo, M.-D., & Cheng, T. (2009) · IEEE International Conference on Bioinformatics and Bioengineering (BIBE) · doi:10.1109/bibe.2009.79
Antiviral Therapy for Chronic HCV Infection: Virological Response and Long-Term Outcome
van der Meer, A. J. (2014) · EUR Research Repository (Erasmus University Rotterdam)
Hepatitis C — Overview and Update in Treatment
Alghamdi, A. S. (2015) · InTech eBooks · doi:10.5772/60949
Genotypische Charakterisierung von Resistenzmutationen in der Hepatitis C Virus-Quasispezies unter Therapie mit einem Hepatitis C-spezifischen Proteaseinhibitor
Lammert, F. (2008)

Authors: Hoofnagle, J. H.
Affiliations: National Institutes of Health (US)
Corresponding author: Hoofnagle, J H
Venue: Hepatology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1997-12
Volume: 26
Issue: Supplement 3
Pages: 15S-20S
ISSN: 0270-9139 (ISSN-L)
DOI: 10.1002/hep.510260703
OpenAlex: W1979931682
Cited by: 765
References: 47
Citations by year: 2026: 3 · 2025: 8 · 2024: 11 · 2023: 8 · 2022: 8 · 2021: 14 · 2020: 9 · 2019: 10 · 2018: 14 · 2017: 11 · 2016: 25 · 2015: 20 · 2014: 32 · 2013: 26 · 2012: 20
FWCI: 27.00
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 6483 d)
Locations: Hepatology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Hepatitis C virus research
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords: hepatitis C, hepatitis C virus, acute hepatitis C, chronic hepatitis C, end-stage liver disease, liver cirrhosis, hepatocellular carcinoma, extrahepatic manifestations, cryoglobulinemia, glomerulonephritis, aminotransferase elevation, HCV RNA, incubation period, clinical spectrum
MeSH terms: Acute Disease, Transaminases, Chronic Disease, Hepatitis C, Humans, Severity of Illness Index, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hepatitis C: the clinical spectrum of disease.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks